Spain has officially joined the Genome of Europe project, an initiative led by the Carlos III Health Institute and accompanied by various national research centres. The project aims to establish the largest catalogue of DNA in Europe, collecting one hundred thousand genomes representing the continent’s population. This cornerstone effort seeks to pioneer biomedical science by improving the prediction, prevention, diagnosis, and treatment of various diseases including cancer and rare disorders.

With a total funding of forty-five million euros, Spain contributes around three million euros as part of its commitment to advancing healthcare through personalised medicine. The project involves twenty-seven countries and more than one hundred experts from numerous European research institutions, aimed at integrating genomic data into European health systems. The Spanish participation is particularly significant as it plans to sequence twelve thousand genomes from its population.

The initiative will be supported by Spain’s IMPaCT infrastructure for Precision Medicine, which is already operational and includes primary care centres across the country. The concern for ethical and legal aspects will be managed by the University of the Basque Country, while the CNAG and CNIO will oversee genomic sequencing activities. This collaboration emphasises that understanding DNA is crucial for the realisation of personalized medicine.

By participating in the Genome of Europe project, Spain reiterates its dedication to becoming an important player in the European Research Area. This initiative not only fosters innovation in genomic technologies but also aims to enhance health outcomes for people throughout Europe.